Bio-Rad Genesis Cell Isolation System -- Notice of Intent to Award to a Sole Source Tender

Procurement Summary

Country: USA

Summary: Bio-Rad Genesis Cell Isolation System -- Notice of Intent to Award to a Sole Source

Deadline: 05 Aug 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 123679211

Document Ref. No.: 36C26125Q0799

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description

This is a notice of intent to solicit and award a sole source firm fixed price contract under the authority of FAR 13.106-1(b)(1), only one source being available to meet the Government-s need. The contract estimated delivery will be sixty (60) days after receipt of order (ARO).

The North American Industrial Classification System (NAICS) code for this procurement is 334516 Laboratory analytical instruments (except optical) manufacturing, with a small business size standard of 1, 000 employees. The FSC/PSC is 6632 Analysis Instruments, Medical Laboratory Use.

The Department of Veterans Affairs, Veterans Health Administration, Regional Procurement Office West, Network Contracting Office (NCO) 21, for the Veterans Integrated Service Network (VISN 21), intends to solicit and award a sole source firm fixed price contract for the purchase of Bio-Rad Genesis Cell Isolation System to Bio-Rad 2000 Alfred Nobel Drive, Hercules, CA 94547-1801. There is no other source of supply that will satisfy agency requirements.

The VA Northern California Health Care System, Sacramento VA Medical Center intends to purchase the Bio-Rad Genesis Cell Isolation System, an automated, microfluidic-based instrument used to isolate rare cells (such as circulating tumor cells and immune subsets) from whole blood or other liquid biopsy samples. This system will be used for oncology research involving liquid biopsy analysis.

The Genesis system is unique in that it enabled multiple workflows (enrichment and enumeration) on the same instrument and enables a superior capture efficiency compared to alternative approaches along with customization options to enable optimization for a variety of sample types and target cells. A key unique feature is the high viability of captured cells, in a label-free manner, that enable the compatibility with sensitive downstream applications such as single-cell RNA sequencing and digital PCR workflows. Competing technologies (e.g., antibody...
Active Contract Opportunity
Notice ID : 36C26125Q0799
Related Notice
Department/Ind. Agency : VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier : VETERANS AFFAIRS, DEPARTMENT OF
Office: 261-NETWORK CONTRACT OFFICE 21 (36C261)
General Information
Contract Opportunity Type: Special Notice (Updated)
Updated Published Date: Jul 30, 2025 01:29 pm PDT
Original Published Date: Jul 30, 2025 01:22 pm PDT
Updated Response Date: Aug 05, 2025 03:00 pm PDT
Original Response Date: Aug 05, 2025 03:00 pm PDT
Inactive Policy: 15 days after response date
Updated Inactive Date: Aug 20, 2025
Original Inactive Date: Aug 20, 2025
Initiative: None

Classification
Original Set Aside:

Product Service Code: 6632 - ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE
NAICS Code: 33451 - Navigational, Measuring, Electromedical, and Control Instruments Manufacturing

Place of Performance: Mather, CA 95655 USA

Documents

 Tender Notice